Plan to attend Industry Non-CME Programs
Sponsored programming features the latest innovations.
Industry Non-CME (INC) Programs will return to the 2024 AAD Annual Meeting and will highlight the latest innovations directly from industry. INC programming, which is at the sponsor’s discretion, will feature new research findings, showcase specialty innovations, conduct demonstrations, and serve up lively discussions.
INC programs take place after scientific sessions in the evening and are solely developed and delivered by the sponsor. They do not qualify for continuing medical education credit. Pre-registration and food and beverage may be provided by the sponsoring company. You can also keep this link handy for the latest updates or favorite select programs in the AAD Meeting app.
Thursday, March 7
Chronic Hand Eczema: Putting the Pieces Together
6:30 p.m. Registration; 7 p.m. Program
Location: Indigo Ballroom AE | Hilton San Diego Bayfront
Sponsor: LEO Pharma
Chronic Hand Eczema is a condition with considerable impact to patients' quality of life. It has many etiologies and is often refractory to treatment. Please join your colleagues for an interactive conversation with Dr. Jonathan Silverberg, Dr. Eric Simpson, and Dr. Larry Eichenfield where they will discuss clinical considerations around this heterogenous disease and review current recommendations for diagnosis and treatment.
The IL-17 Family: In a Crowded Field, How One Cytokine is Changing the Game
6:30 p.m. Registration; 7 p.m. Program
Location: Indigo Ballroom DH | Hilton San Diego Bayfront
Platinum Sponsor: UCB
Join us to explore the IL-17 family of cytokines and the integral role they play in the inflammatory process of immune-mediated skin diseases, including psoriasis, psoriatic arthritis, and hidradenitis suppurativa. Evolving understanding of the central inflammatory drivers of these diseases is leading to significant improvements in outcomes for patients.
What is the OX40 Ligand Pathway? Unlocking a New Frontier in Atopic Dermatitis
6:30 p.m. Registration; 7 p.m. Program
Location: Harbor Ballroom GHI | Manchester Grand Hyatt
Sponsor: Sanofi
In this industry-supported Non-CME program, Dr. April Armstrong and Dr. Shawn Kwatra will discuss unmet needs in atopic dermatitis and provide education on OX40 ligand as a driver of disease and a novel treatment target. In an engaging forum, they will share clinical development updates and their perspectives on how targeting OX40 ligand may have the potential to improve outcomes among the highly heterogeneous patient population with atopic dermatitis.
Friday, March 8
Review of SOTYKTU™ (deucravacitinib) Product Data, including from its Long-Term Extension Trial
6:30 p.m. Registration; 7 p.m. Program
Location: Indigo Ballroom AE | Hilton San Diego Bayfront
Platinum Sponsor: Bristol Myers Squibb
This industry-supported Non-CME program, including a panel discussion, will describe the efficacy and safety profile of an oral product. Learn more about the pivotal clinical trials, long-term extension data, and product function, and hear from experts.
Advancing Patient Care in Chronic Spontaneous Urticaria: Reshaping the Future with Targeted Biologic Therapies
6:30 p.m. Registration; 7 p.m. Program
Location: Indigo Ballroom DH | Hilton San Diego Bayfront
Sponsor: PeerView Institute
In order to help clinicians remain familiar with newly available/emerging treatment options and their optimal positioning in the therapeutic algorithm for CSU, PeerView has prepared this live educational event utilizing the latest data and a case-based practicum. Drs. April W. Armstrong and Jason K. Lee will discuss strategies to improve diagnosis and how to incorporate currently available and emerging biologic agents, such as omalizumab and dupilumab, into the treatment of patients with CSU. Supported by an independent educational grant from Sanofi and Regeneron. Learn more and register.
Visible Results Across the Many Shades of Moderate to Severe Plaque Psoriasis
6:30 p.m. Registration; 7 p.m. Program
Location: Pacific Ballroom 21 - 26 | Marriott Marquis San Diego
Platinum Sponsor: Johnson & Johnson
Join us for a case-based conversation with leading experts about treating moderate to severe plaque psoriasis across diverse skin tones including a discussion of new data. At the end of the symposium, attendees will be able to:
- Highlight key differences in clinical presentation of plaque psoriasis across diverse skin tones.
- Review unique considerations in patients with skin of color that have plaque psoriasis.
- Understand new data from a first-of-its-kind prospective skin of color psoriasis trial. able
Day One Premiere: Living With Alopecia Areata
6:30 p.m. Registration, 7 p.m. Program
Location: Harbor Ballroom GHI | Manchester Grand Hyatt
Sponsor: Pfizer, Inc.
Every patient with alopecia areata (AA) has a unique journey living with their disease and is impacted by the disease in different ways. In this Pfizer-sponsored Industry Non-CME (INC) Program, participants will experience the premiere of the short film, Day One: Living With Alopecia Areata, which follows a day in the life of three patients with AA and explores how living with AA affects the fundamentals of modern life. In addition to the film, a panel of experts will discuss the need for the medicalization of AA; what can be done to enhance recognition of the true nature of this complex autoimmune disease, and how, by improving public awareness and reducing stigma, we can empower patients to take control of their disease.
Saturday, March 9
The Benefits of Early Intervention in AD: More than Skin Deep
6:30 p.m. Registration; 7 p.m. Program
Location: Indigo Ballroom AE | Hilton San Diego Bayfront
Sponsor: Sanofi and Regeneron
Many AD treatment goals focus on clinical manifestations, so that if a patient is free of lesions, their disease is considered well controlled. However, the inflammatory process underlying AD reaches far beyond the skin, affecting patients in unique ways at different stages of their lives. Education on the importance of treating AD beyond the skin and altering the treatment approach to fit the individual patient will help improve clinical management and reduce long-term patient burden.
Speakers: Eric Simpson, MD, MSCR; Lawrence F. Eichenfield, MD; and Katrina Abuabara, MD, MA, MSCE. Learn more and register.
Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making
6:30 p.m. Registration; 7 p.m. Program
Location: Indigo Ballroom DH | Hilton San Diego Bayfront
Platinum Sponsor: Physicians’ Education Resource
The purpose of this educational program is to expand clinicians’ knowledge and understanding of HS as an immune-mediated inflammatory disease, disease manifestations, and pathophysiology. Through panel discussion, faculty will discuss applying assessments of disease severity and multimodal treatment approaches in order to optimize disease management and treatment outcomes. Supported by an unrestricted independent educational grant from Novartis Pharmaceuticals & Incyte.
Perspectives on Itch: Sharing Experiences and Understanding the Burden, a Galderma Symposium in Collaboration with the National Eczema Association
6:30 p.m. Registration; 7 p.m. Program
Location: Pacific Ballroom 21 - 26 | Marriott Marquis San Diego
Sponsor: Galderma
Itch is one of the most burdensome and debilitating symptoms associated with diseases such as atopic dermatitis or prurigo nodularis. Despite its detrimental impact on patient quality of life, it can be overlooked and underappreciated. Recognizing itch needs to serve as a priority in identification and treatment of pruritic diseases. How can dermatology providers better recognize and address itch in busy practices? Join us for a cutting-edge and patient-centric discussion with leading experts in itch. This Galderma program has been developed in collaboration with the National Eczema Association.
Speakers: Wendy Smith Begolka, MBS; Shawn Kwatra, MD; Jonathan Silverberg, MD, PHD, MPH; and Matt Zirwas, MD. Learn more and register.
Expert Forum: Navigating the Spectrum of Skin Color in Dermatology
6:30 p.m. Registration; 7 p.m. Program
Location: Harbor Ballroom GHI | Manchester Grand Hyatt
Platinum Sponsor: Pfizer, Inc.
As the U.S. population becomes increasingly diverse, dermatologists will be required to apply better equity and cultural competence in their daily practice to meet the needs of individual patients. In this Pfizer-sponsored Industry Non-CME (INC) Program, a panel of experts will share considerations for managing patients with skin of color and diverse backgrounds and describe best practices for individualized patient care. During the session, participants will learn to appreciate the heterogeneous clinical presentation and disease burden of atopic dermatitis (AD), alopecia areata (AA), and vitiligo across diverse skin types and patient backgrounds, and the implications these have on clinical practice.
Sunday, March 10
Aiming High: Optimizing Outcomes in Moderate to Severe Atopic Dermatitis Using Advanced Biologic Therapies
6:30 p.m. Registration; 7 p.m. Program
Location: Indigo Ballroom DH | Hilton San Diego Bayfront
Sponsor: Medscape, LLC
This Industry Non-CME program is an interactive case-based educational initiative for clinicians. The 60-minute live symposium will include two patient cases and will utilize active collaboration to drive learner engagement and problem-solving. Small groups allow for discussion and exploration of current practice strategies, as well as clinical practice reflection to help learners understand treatment advancements and key considerations for when to switch therapy for patients with moderate to severe atopic dermatitis. Supported by an independent educational grant from Lilly. Learn more and register.
A Tale of Two Itches: Bridging the Gap with Type 2 Inflammation in Prurigo Nodularis and Chronic Spontaneous Urticaria
6:30 p.m. Registration; 7 p.m. Program
Location: Indigo Ballroom AE | Hilton San Diego Bayfront
Platinum Sponsor: Sanofi and Regeneron
In this symposium, internationally renowned itch experts will explore how two very distinct diseases with seemingly unrelated clinical features can share an underlying pathomechanism manifesting in chronic signs and symptoms. In the context of prurigo nodularis (PN) and chronic spontaneous urticaria (CSU), the presenters will showcase the latest research on itch pathophysiology and the neuro-immune mechanisms that drive their unique disease characteristics. The expert panel will explore new pathways and how type 2 inflammatory cytokines interact with the nerves and surrounding tissue milieu, perpetuating the chronic itch and lesion formation characteristic of both PN and CSU and mechanistically linking these two distinct skin diseases.
Speakers: Sarina B. Elmariah, MD, PhD, MPH; Martin Metz, MD; and Brian S. Kim, MD, MTR, FAAD. Learn more and register.
Patient-Centric Management of Actinic Keratosis
6:30 p.m. Registration; 7 p.m. Program
Location: Harbor Ballroom GHI | Manchester Grand Hyatt
Sponsor: Medscape, LLC
Patient-Centric Management of Actinic Keratosis is a 75-minute live, independent medical education symposium and livestream that will blend didactic and case-based discussion to present current evidence-based treatment of actinic keratosis and contextualize patient-centric management. Supported by an independent educational grant from Almirall, LLC and Sun Pharmaceutical Industries, Inc. Learn more and register.
